BRIDGEWATER, NJ--(Marketwire - May 9, 2008) - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced the filing of its Form 10-Q for the quarter ended March 31, 2008. First quarter 2008 results include a net gain of $209.5 million, or earnings per share (“EPS”) of $4.85, related to the sale of the Active Pharmaceutical Ingredients business. The reported gain reflects an adjustment of $8.0 million from the amount previously reported on May 5, 2008. The gain is subject to further adjustments based on the closing net cash balance and working capital of the business, as defined in the divestiture agreement. Previously reported total stockholders’ equity and results from continuing operations for the first quarter of 2008 are unchanged, and total first quarter 2008 EPS, including results from discontinued operations, was $3.96.
